Phenformin NEW
Price | $149 | $218 | $318 |
Package | 25mg | 50mg | 100mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-19 |
Product Details
Product Name: Phenformin | CAS No.: 114-86-3 |
Purity: 97.07% | Supply Ability: 10g |
Release date: 2024/11/19 |
Product Introduction
Bioactivity
Name | Phenformin |
Description | Phenformin (BRN 1977317) is a biguanide compound with anticancer and anti-glycemic activity, inhibits skin tumor growth and promotes keratinocyte differentiation and apoptosis. |
In vitro | Phenformin acts by promoting phosphorylation and activation of AMPKalpha1 and AMPKalpha2 without altering the activity of the LKB1 gene [1]. In isolated hearts, Phenformin increased AMPK activity and phosphorylation levels, which correlated with increased AMPK activity and increased intracellular [AMP] [2].Phenformin was 50 times more potent than Metformin and was able to inhibit mitochondrial complex I. In LKB1-deficient non-small cell lung cancer cell lines, the Phenformin was able to induce apoptosis.Phenformin (2 mM) also induced AMPK signaling and increased levels of P-AMPK and P-Raptor.Phenformin induced higher levels of cellular stress, which in turn triggered the induction of P-Ser51 eIF2α and its downstream target CHOP, which are late stage molecular markers of apoptosis. In chronically treated KLluc mice, Phenformin induced survival and treatment response [3]. In H441 cells, Phenformin and AICAR increased AMPK activity in a dose-dependent manner, maximizing activation of the kinase at 5-10 mM and 2 mM concentrations. In H441 cell monolayers, Phenformin significantly reduced basal ion migration (measured as short-circuit current) by approximately 50%. Phenformin and AICAR significantly reduced amiloride-sensitive transmembrane Na ion transport compared to controls. Phenformin and AICAR inhibited amiloride-sensitive transmembrane Na ion transport in H441 cells by activating AMPK and inducing inhibition of sodium ion entry at the terminal and basolateral sides of ENaC cells via the Na+, K+ ATPase [4]. In rats treated with Phenformin, their blood insulin levels tend to decrease (radioimmunoassay) [5]. |
Storage | keep away from direct sunlight,store at low temperature,keep away from moisture,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : Soluble |
Keywords | BRN1977317 | Phenformin | BRN-1977317 |
Inhibitors Related | Stavudine | 5-Fluorouracil | Acetylcysteine | Myricetin | Sodium 4-phenylbutyrate | L-Ascorbic acid | Dextran sulfate sodium salt (MW 4500-5500) | Metronidazole | Sorafenib | Tributyrin |
Related Compound Libraries | Bioactive Compound Library | Drug Repurposing Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$10.50/1KG |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-21 | |
$999.00/5g |
VIP1Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2024-08-09 | |
$0.00/1gram |
VIP4Y
|
Zhejiang J&C Biological Technology Co.,Limited
|
2022-02-17 | |
$9.80/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-02-10 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY